Cargando…
Bosentan for high-risk outpatients with COVID-19 infection: a randomized, double blind, placebo-controlled trial
BACKGROUND: The endothelium is supposedly activated and damaged in COVID-19 because of endothelin-1 over-secretion. This study evaluates the effect of bosentan as an endothelin receptor blocker on the progression of disease in high-risk outpatients with COVID-19 infection. METHODS: From 15 December...
Autores principales: | Shahbazi, Shaahin, Vahdat Shariatpanahi, Zahra, Shahbazi, Erfan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404861/ https://www.ncbi.nlm.nih.gov/pubmed/37554128 http://dx.doi.org/10.1016/j.eclinm.2023.102117 |
Ejemplares similares
-
Refeeding Syndrome and Its Related Factors in Critically Ill Coronavirus Disease 2019 Patients: A Prospective Cohort Study
por: Vahdat Shariatpanahi, Zahra, et al.
Publicado: (2022) -
Implementation of a Case Presentation Program for Clinical Nutrition Students
por: Shahbazi, Shaahin, et al.
Publicado: (2022) -
The validity of the global leadership initiative on malnutrition criteria for diagnosing malnutrition in critically ill patients with COVID-19: A prospective cohort study
por: Shahbazi, Shaahin, et al.
Publicado: (2021) -
Protein and Energy Intake Assessment and Their Association With In-Hospital Mortality in Critically Ill COVID-19 Patients: A Prospective Cohort Study
por: Hajimohammadebrahim-Ketabforoush, Melika, et al.
Publicado: (2021) -
Evaluation of anorexia and analysis of related factors in patients with COVID-19
por: Shahbazi, Shaahin, et al.
Publicado: (2022)